Athanassios Vozikis
Athanassios Vozikis
Associate Professor, Laboratory of Health Economics and Management (LabHEM), University of Piraeus
Verified email at - Homepage
Cited by
Cited by
Patient satisfaction with the healthcare system: Assessing the impact of socio-economic and healthcare provision factors
S Xesfingi, A Vozikis
BMC health services research 16 (1), 1-7, 2016
Health literacy among university students in Greece: determinants and association with self-perceived health, health behaviours and health risks
A Vozikis, K Drivas, K Milioris
Archives of Public Health 72 (1), 1-6, 2014
eHealth Literacy: In the Quest of the Contributing Factors
S Xesfingi, A Vozikis
Interactive Journal of Medical Research 5 (2), e16, 2016
Information management of medical errors in Greece: The MERIS proposal
A Vozikis
International Journal of Information Management 29 (1), 15-26, 2009
The recent and projected public health and economic benefits of cigarette taxation in Greece
HR Alpert, CI Vardavas, FJ Chaloupka, A Vozikis, K Athanasakis, ...
Tobacco control 23 (5), 452-454, 2014
Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke
C Mitropoulou, V Fragoulakis, N Bozina, A Vozikis, S Supe, T Bozina, ...
Pharmacogenomics 16 (2), 137-148, 2015
Test pricing and reimbursement in genomic medicine: towards a general strategy
A Vozikis, DN Cooper, C Mitropoulou, ME Kambouris, A Brand, V Dolzan, ...
Public Health Genomics 19 (6), 352-363, 2016
MERIS (Medical Error Reporting Information System) as an innovative patient safety intervention: A health policy perspective
M Riga, A Vozikis, Y Pollalis, K Souliotis
Health policy 119 (4), 539-548, 2015
Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece
Y Mai, C Mitropoulou, XE Papadopoulou, A Vozikis, DN Cooper, ...
Personalized Medicine 11 (1), 15-26, 2014
Pharmacogenomics and public health: implementing 'populationalized' medicine
L Mette, K Mitropoulos, A Vozikis, GP Patrinos
Pharmacogenomics 13 (7), 803-813, 2012
Medical decision making for patients with Parkinson disease under Average Cost Criterion
A Vozikis, JE Goulionis
Australia and New Zealand health policy 6 (1), 2009
Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance
DN Cooper, A Brand, V Dolzan, P Fortina, F Innocenti, MT Michael Lee, ...
Personalized medicine 11 (7), 615-623, 2014
Going up in ashes? Smoking-attributable morbidity, hospital admissions and expenditure in Greece
K Tsalapati, CI Vardavas, K Athanasakis, E Thireos, A Vozikis, E Pavi, ...
The European Journal of Public Health 24 (3), 477-479, 2014
Stakeholder analysis in pharmacogenomics and genomic medicine in Greece
C Mitropoulou, Y Mai, RH Van Schaik, A Vozikis, GP Patrinos
Public Health Genomics 17 (5-6), 280-286, 2014
Relevance of pharmacogenomics for developing countries in Europe
K Mitropoulos, L Johnson, A Vozikis, GP Patrinos
Walter de Gruyter 26 (4), 143-146, 2011
Impact of cigarette price differences across the entire European Union on cross-border purchase of tobacco products among adults in 2012
I Agaku, E Blecher, O Uyoyo, F Filippidis, A Vozikis, C Vardavas
Tobacco Control, doi:10.1136/tobaccocontrol-2014-052015, 2015
Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention
C Mitropoulou, V Fragoulakis, LB Rakicevic, MM Novkovic, A Vozikis, ...
Pharmacogenomics 17 (16), 1775-1784, 2016
Application of economic evaluation to assess feasibility for reimbursement of genomic testing as part of personalized medicine interventions
S Simeonidis, S Koutsilieri, A Vozikis, DN Cooper, C Mitropoulou, ...
Frontiers in pharmacology 10, 830, 2019
Estimates of price and income elasticity in Greece. Greek debt crisis transforming cigarettes into a luxury good: an econometric approach
F Tarantilis, K Athanasakis, D Zavras, A Vozikis, I Kyriopoulos
BMJ open 5 (1), e004748, 2015
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
V Fragoulakis, M Bartsakoulia, X Díaz-Villamarín, K Chalikiopoulou, ...
The pharmacogenomics journal 19 (5), 438-445, 2019
The system can't perform the operation now. Try again later.
Articles 1–20